|Table of Contents|

Research progress on the relationship between chronic periodontitis and oral squamous cell carcinoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 06
Page:
1117-1120
Research Field:
Publishing date:

Info

Title:
Research progress on the relationship between chronic periodontitis and oral squamous cell carcinoma
Author(s):
WANG Wei; ZHANG Ruimin
Department of Periodontal Mucosal Bramh，the Second Affiliated Hospital of Harbin Medical University，Heilongjiang Harbin 150086，China.
Keywords:
oral squamous cell carcinoma(OSCC); chronic periodontitis; periodontal pathogens; cytokines; NF-κB
PACS:
R739.85
DOI:
10.3969/j.issn.1672-4992.2022.06.035
Abstract:
The incidence rate and mortality of oral squamous cell carcinoma(OSCC) are increasing and younger,which has become a major public health problem worldwide.In recent years,more and more attention has been paid to the relationship between chronic periodontitis(CP) and oral squamous cell carcinoma(OSCC).Some studies have also found that periodontal disease characterized by chronic inflammation and microbial imbalance is an important risk factor for oral cancer.In this paper,the related research of chronic periodontitis and oral squamous cell carcinoma,the bridge role of periodontal pathogens,cytokines,NF-κB in the two,and the application of anti-inflammatory drugs in oral squamous cell carcinoma are mainly described.

References:

［1］蒋文贤,陈培富.慢性炎症与癌症关系研究进展［J］.动物医学进展,2019,40(03):114-118. JIANG WX,CHEN PF.Research progress on the relationship between chronic inflammation and cancer［J］.Progress in Veterinary Medicine,2019,40(03):114-118.
［2］BABIC A,SCHNURE N,NEUPANE NP,et al.Plasma inflammatory cytokines and survival of pancreatic cancer patients［J］.Clinical & Translational Gastroenterology,2018,9(4):145.
［3］AXLEY P,AHMED Z,RAVI S,et al.Hepatitis C virus and hepatocellular carcinoma:a narrative review［J］.Journal of Clinical & Translational Hepatology,2018,6(2):79-84.
［4］BAIG MS,BHUTTO RA,MUHAMMAD S,et al.Epidemiology of oral cancer in Southern Punjab,Pakistan［J］.Pakistan Journal of Medical and Health Sciences,2015,9(4):1269-1271.
［5］POURYA,GHOLIZADEH,HOSEIN,et al.Role of oral microbiome on oral cancers,a review［J］.Biomedicine & Pharmacotherapy,2016,84:552-558.
［6］OLSEN I,PROGULSKE-FOX A.Invasion of Porphyromonas gingivalis strains into vascular cells and tissue［J］.Journal of Oral Microbiology,2015,7:28788.
［7］S BUKET BOZKURT,SEMA S HAKKI,ERDOGAN E HAKKI,et al.Porphyromonas gingivalis lipopolysaccharide induces a pro-inflammatory human gingival fibroblast phenotype［J］.Inflammation,2017,40(1):144-153.
［8］BRIAN,BURT.Position paper:epidemiology of periodontal diseases［J］.J Periodontol,2005,8:1406-1419.
［9］KRGER MAXIMILIAN,TORSTEN H,ADRIAN K,et al.The correlation between chronic periodontitis and oral cancer［J］.Case Reports in Dentistry,2013,2013:262410.
［10］MOERGEL M,KAMMERER P,KASAJ A,et al.Chronic periodontitis and its possible association with oral squamous cell carcinoma-a retrospective case control study［J］.Head Face Med,2013,9:39.
［11］LI S,LIU X,ZHOU Y,et al.Shared genetic and epigenetic mechanisms between chronic periodontitis and oral squamous cell carcinoma［J］.Oral Oncology,2018,86:216-224.
［12］SAYEHMIRI F,SAYEHMIRI K,ASADOLLAHI K,et al.The prevalence rate of Porphyromonas gingivalis and its association with cancer:A systematic review and meta-analysis［J］.International Journal of Immunopathology & Pharmacology,2015,28(2):160-167.
［13］LEE J,ROBERTS JS,ATANASOVA KR,et al.Human primary epithelial cells acquire an epithelial-mesenchymal-transition phenotype during long-term infection by the oral opportunistic pathogen［J］.Front Cell Infect Microbiol,2017,7:493.
［14］GALVAO-MOREIRA LV,DA CRUZ MCFN.Oral microbiome,periodontitis and risk of head and neck cancer［J］.Oral Oncology,2016,53:17-19.
［15］KHAN S,JAIN M,MATHUR V,et al.Chronic inflammation and cancer:paradigm on tumor progression,metastasis and therapeutic intervention［J］.Gulf Journal of Oncology,2016,1(20):86.
［16］OLSEN I,YILMAZ Z.Possible role of Porphyromonas gingivalis in orodigestive cancers［J］.Journal of Oral Microbiology,2019,11(1):1563410.
［17］KATZ J,ONATE MD,PAULEY KM,et al.Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma［J］.International Journal of Oral Science,2011(4):209-215.
［18］PARK,WOO,LEE,et al.Serum levels of interleukin-6 and titers of antibodies against porphyromonas gingivalis could be potential biomarkers for the diagnosis of oral squamous cell carcinoma［J］.International Journal of Molecular Sciences,2019,20(11):2749.
［19］GAO SG,YANG JQ,MA ZK,et al.Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma［J］.Bmc Cancer,2018,18(1):17.
［20］CHEN Y，ZHOU Ｒ，YI Z，et al． Porphyromonas gingivalisinduced in flammatory responses and promoted apoptosis in lung epithelial cells infected with H1N1 via the Bcl － 2 /Bax /Caspase － 3 signaling pathway［J］． Molecular Medicine Ｒeports，2018，18(1):97－104．
［21］CHOI CH，SPOONER Ｒ，DEGUZMAN J，et al． Porphyromonas gingivalis － nucleoside － diphosphate － kinase inhibits ATP － induced reactive － oxygen － species via P2X7 receptor/NADPH － oxidase signalling and contributes to persistence［J］． Cell Microbiol，2013，15(6):961-976．
［22］GROEGER S，JARZINA F，MAMAT U，et al． Induction of B7 － H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells:B7－H1 induction by Porphyromonas gingivalis fractions［J］． Immunobiology，2017，222(2):137．
［23］RUBINSTEIN MR,BAIK JE,LAGANA SM,et al.Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1［J］.Embo Reports,2019，20：e47638.
［24］Unus S Narasimham,Gunasekaran N,Krishnan R,et al.Role of cytokines in oral malignancies［J］.Srm Journal of Research in Dental Sciences,2014，5:274-279.
［25］HENNE K,SCHILLING H,STONEKING M,et al.Sex-specific differences in the occurrence of Fusobacterium nucleatum subspecies and Fusobacterium periodonticum in the oral cavity［J］.Oncotarget，2018，9：20631-20639.
［26］SAHIBZADA HA,KHURSHID Z,KHAN RS,et al.Salivary IL-8,IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer［J］.Diagnostics(Basel)，2017,7(2):21.
［27］ZENG C,KUANG H,FAN W,et al.Downregulation of FOXP3 in neutrophils by IL8 promotes the progression of oral squamous cell carcinoma［J］.Oncology Letters,2019,18(5):4771-4777.
［28］KAMPEROS G,NIKITAKIS N,SFAKIANOU A,et al.Expression of NF-κB and IL-6 in oral precancerous and cancerous lesions:An immunohistochemical study［J］.Medicina Oral Patologia Oral Y Cirugia Bucal,2016,21(1):e6-e13.
［29］HSING EW,SHIAH SG,PENG HY,et al.TNF-α-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility［J］.PLoS One,2019,14(3):e0213463.
［30］REZAEI F,MOZAFFARI HR,TAVASOLI J,et al.Evaluation of serum and salivary interleukin-6 and interleukin-8 levels in oral squamous cell carcinoma patients:systematic review and Meta-analysis［J］.Interferon Cytokine Res,2019,39(12):727-739.
［31］MARIA ROSARIA GALDIERO,EDUARDO BONAVITA,ISABELLA BARAJON,et al.Tumor associated macrophages and neutrophils in cancer［J］.Journal of Cellular Physiology,2013,218(11):1402-1410.
［32］PERKINS NEIL D.Integrating cell-signalling pathways with NF-kappaB and IKK function［J］.Nat Rev Mol Cell Biol,2007,8(1):49-62.
［33］LI X,GUO S,XIONG XK,et al.Combination of quercetin and cisplatin enhances apoptosis in OSCC cells by downregulating xIAP through the NF-κB pathway［J］.Journal of Cancer,2019,10(19):4509-4521.
［34］AMANDA R,ALBERT B.The NF-κB pathway and cancer stem cells［J］.Cells,2016,5(2):16.
［35］SCAPOLI L,PALMIERI A,LO ML,et al.MicroRNA expression profiling of oral carcinoma identifies new markers of tumor progression［J］.International Journal of Immunopathology & Pharmacology,2010,23(4):1229.
［36］BAYRAKTAR R,VAN ROOSBROECK K.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics［J］.Cancer Metastasis Rev,2018，37（1）:33-34.
［37］MORATIN J SCHOLZ.Evaluation of miRNA-expression and clinical tumour parameters in oral squamous cell carcinoma(OSCC)［J］.Journal of Cranio Maxillofacial Surgery,2016,44(7):876-881.
［38］BANO N,YADAV M,MOHANIA D,et al.The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection［J］.PLoS One,2018,13(10):e0205518.
［39］DIAKOS CI,CHARLES KA,MCMILLAN DC,et al.Cancer-related inflammation and treatment effectiveness［J］.Lancet Oncol,2014,15(11):493-503.
［40］ANTUNES DM,MFSD R,GUIMARAES DM,et al.Nonsteroidal anti-inflammatory drugs modulate gene expression of inflammatory mediators in oral squamous cell carcinoma［J］.Anticancer Research,2019,39(5):2385-2394.
［41］XIAOQI Z,HAO F,ZIYU L,et al.Aspirin is involved in the cell cycle arrest,apoptosis,cell migration,and invasion of oral squamous cell carcinoma［J］.International Journal of Molecular Sciences,2018,19(7):2029.
［42］CHENG-WEN LIN,HSIEN-KUO CHIN,SHOU-LUN LEE,et al.Ursolic acid induces apoptosis and autophagy in oral cancer cells［J］.Environmental Toxicology,2019,34(9):983-991.

Memo

Memo:
黑龙江省卫生计生委科研课题(编号:2017－082)
Last Update: 1900-01-01